Type I Interferon Signaling in Dendritic Cells Stimulates the Development of Lymph-Node-Resident T Follicular Helper Cells
|
journal
|
September 2009 |
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
|
journal
|
August 2013 |
Germinal Centers
|
journal
|
April 2012 |
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life
|
journal
|
April 2015 |
Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
|
journal
|
June 2014 |
Activin A programs the differentiation of human TFH cells
|
journal
|
July 2016 |
T Follicular Helper Cell Differentiation, Function, and Roles in Disease
|
journal
|
October 2014 |
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
|
journal
|
September 2011 |
Decreased T Follicular Regulatory Cell/T Follicular Helper Cell (T FH ) in Simian Immunodeficiency Virus–Infected Rhesus Macaques May Contribute to Accumulation of T FH in Chronic Infection
|
journal
|
August 2015 |
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
|
journal
|
February 2017 |
Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem
|
journal
|
January 2017 |
Quality and quantity of T FH cells are critical for broad antibody development in SHIV AD8 infection
|
journal
|
July 2015 |
Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
|
journal
|
December 2017 |
Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory
|
journal
|
September 2014 |
Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells
|
journal
|
November 2017 |
Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall
|
journal
|
June 2015 |
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
|
journal
|
June 2016 |
Designing therapeutic cancer vaccines by mimicking viral infections
|
journal
|
April 2016 |
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
|
journal
|
October 2016 |
HPLC Purification of In Vitro Transcribed Long RNA
|
book
|
November 2012 |
In Vitro Transcription of Long RNA Containing Modified Nucleosides
|
book
|
November 2012 |
Materials for non-viral intracellular delivery of messenger RNA therapeutics
|
journal
|
October 2016 |
The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation
|
journal
|
November 2013 |
Germinal Center Selection and the Antibody Response to Influenza
|
journal
|
October 2015 |
Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation
|
journal
|
February 2014 |
Immunogenicity and protective efficacy of influenza vaccination
|
journal
|
July 2004 |
Synthetic DNA vaccine strategies against persistent viral infections
|
journal
|
May 2013 |
Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique
|
journal
|
June 2016 |
Induction of virus-specific cytotoxic T lymphocytesin vivo by liposome-entrapped mRNA
|
journal
|
July 1993 |
Progress in developing virus-like particle influenza vaccines
|
journal
|
May 2016 |
Water-in-Oil–Only Adjuvants Selectively Promote T Follicular Helper Cell Polarization through a Type I IFN and IL-6–Dependent Pathway
|
journal
|
October 2016 |
Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope
|
journal
|
October 2004 |
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
|
journal
|
May 2012 |
mRNA vaccines — a new era in vaccinology
|
journal
|
January 2018 |
Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity
|
journal
|
July 2013 |
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
|
journal
|
June 2017 |
Targeting Antigen to Mouse Dendritic Cells via Clec9A Induces Potent CD4 T Cell Responses Biased toward a Follicular Helper Phenotype
|
journal
|
June 2011 |
A novel, disruptive vaccination technology: Self-adjuvanted RNActive
|
journal
|
October 2013 |
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
|
journal
|
September 2015 |
Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses
|
journal
|
October 2015 |
Novel universal influenza virus vaccine approaches
|
journal
|
April 2016 |
Modified mRNA Vaccines Protect against Zika Virus Infection
|
journal
|
March 2017 |
N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
|
journal
|
November 2015 |
Measuring HIV Neutralization in a Luciferase Reporter Gene Assay
|
book
|
January 2009 |
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
|
journal
|
June 2017 |
Skin dendritic cells induce follicular helper T cells and protective humoral immune responses
|
journal
|
November 2015 |
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
|
journal
|
November 2008 |
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
|
journal
|
July 2005 |
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
|
journal
|
October 2017 |
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
|
journal
|
September 2012 |
Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins
|
journal
|
November 2009 |
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
|
journal
|
September 2017 |
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
|
journal
|
August 2013 |
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
|
journal
|
November 2015 |
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
|
journal
|
July 2012 |
Germinal centers
|
book
|
January 2004 |
Modified mRNA Vaccines Protect against Zika Virus Infection
|
journal
|
March 2017 |
Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory
|
journal
|
September 2015 |
Development of vaccines and antivirals for combating viral pandemics
|
journal
|
December 2020 |
Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins
|
text
|
January 2009 |
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|
journal
|
July 2012 |
Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins
|
text
|
January 2009 |
Germinal centers: Germinal centers
|
journal
|
April 2012 |
Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope
|
text
|
January 2004 |
Germinal Centers
|
journal
|
April 2022 |
Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope
|
text
|
January 2004 |
Corrigendum: Induction of Robust B Cell Responses After Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells
|
journal
|
April 2019 |
Induction of virus-specific cytotoxic T lymphocytesin vivo by liposome-entrapped mRNA
|
journal
|
July 1993 |
Designing therapeutic cancer vaccines by mimicking viral infections
|
journal
|
April 2016 |
The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation
|
journal
|
November 2013 |
Germinal Center Selection and the Antibody Response to Influenza
|
journal
|
October 2015 |
Modified mRNA Vaccines Protect against Zika Virus Infection
|
journal
|
March 2017 |
Novel universal influenza virus vaccine approaches
|
journal
|
April 2016 |
Type I Interferon Signaling in Dendritic Cells Stimulates the Development of Lymph-Node-Resident T Follicular Helper Cells
|
journal
|
September 2009 |
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
|
journal
|
September 2012 |
T Follicular Helper Cell Differentiation, Function, and Roles in Disease
|
journal
|
October 2014 |
Skin dendritic cells induce follicular helper T cells and protective humoral immune responses
|
journal
|
November 2015 |
N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
|
journal
|
November 2015 |
Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity
|
journal
|
July 2013 |
Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory
|
journal
|
September 2014 |
Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope
|
journal
|
October 2004 |
Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins
|
journal
|
November 2009 |
Immunogenicity and protective efficacy of influenza vaccination
|
journal
|
July 2004 |
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
|
journal
|
June 2017 |
Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
|
journal
|
December 2017 |
Is there a future for mRNAs as viral vaccines?
|
journal
|
September 2017 |
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
|
journal
|
November 2008 |
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
|
journal
|
August 2013 |
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
|
journal
|
February 2017 |
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
|
journal
|
July 2005 |
Activin A programs the differentiation of human TFH cells
|
journal
|
July 2016 |
mRNA vaccines — a new era in vaccinology
|
journal
|
January 2018 |
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
|
journal
|
August 2013 |
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
|
journal
|
October 2017 |
Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
|
journal
|
June 2014 |
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
|
journal
|
October 2016 |
Progress in developing virus-like particle influenza vaccines
|
journal
|
May 2016 |
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
|
journal
|
May 2012 |
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
|
journal
|
September 2011 |
Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem
|
journal
|
January 2017 |
Germinal Centers
|
journal
|
April 2022 |
Synthetic DNA vaccine strategies against persistent viral infections
|
journal
|
May 2013 |
Corrigendum: Induction of Robust B Cell Responses After Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells
|
journal
|
April 2019 |
Targeting Antigen to Mouse Dendritic Cells via Clec9A Induces Potent CD4 T Cell Responses Biased toward a Follicular Helper Phenotype
|
journal
|
June 2011 |
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life
|
journal
|
April 2015 |
Decreased T Follicular Regulatory Cell/T Follicular Helper Cell (T FH ) in Simian Immunodeficiency Virus–Infected Rhesus Macaques May Contribute to Accumulation of T FH in Chronic Infection
|
journal
|
August 2015 |
Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall
|
journal
|
June 2015 |
Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique
|
journal
|
June 2016 |
Water-in-Oil–Only Adjuvants Selectively Promote T Follicular Helper Cell Polarization through a Type I IFN and IL-6–Dependent Pathway
|
journal
|
October 2016 |
A novel, disruptive vaccination technology: Self-adjuvanted RNActive
|
journal
|
October 2013 |